%0 Journal Article
%T Retinopathy secondary to multiple myeloma treated with bevacizumab.
%A Salcedo Mafla E
%A Gutiérrez Benítez L
%A Asaad M
%J Arch Soc Esp Oftalmol (Engl Ed)
%V 95
%N 10
%D Oct 2020
%M 32636041
暂无%R 10.1016/j.oftal.2020.05.008
%X The case is presented on an 80-year-old woman with IgA multiple myeloma (MM), who developed retinal changes similar to mild non-proliferative diabetic retinopathy, with micro-aneurysms and intraretinal fluid. The patient was treated with systemic chemotherapy for MM, and with bevacizumab intravitreal injections, with control of her ocular disorder for 22 months. Anti-angiogenic therapy can be useful in the control of retinopathy secondary to MM, as long as the systemic disease has been controlled.